Synapse - Advanced Practice Providers

Search Within

Advanced Practice Providers

Results (87)

Outcomes of chronic lymphocytic leukemia and Richter Transformation following discontinuation of noncovalent Bruton's Tyrosine Kinase inhibitors

Meeting Abstract

Thompson, M. C.; Coombs, C. C.; Roeker, L. E.; Pagel, J. M.; Jensen, J. L.; Battiato, K. E.; Fox, Y.; Meyer, K.; Bailey, N.; Rhodes, J. M.; more...
Blood (2021)

Fulltext@MSK | Save

Addressing a new challenge in chronic lymphocytic leukemia: Outcomes of therapies after exposure to both a covalent Bruton's Tyrosine Kinase Inhibitor and venetoclax

Meeting Abstract

Thompson, M. C.; Roeker, L. E.; Coombs, C. C.; Jensen, J. L.; Kamdar, M.; Skarbnik, A.; Pagel, J. M.; Bailey, N.; Pu, J. J.; Jacobs, R.; more...
Blood (2021)

Fulltext@MSK | Save

A phase 2 study evaluating the addition of ublituximab and umbralisib (U2) to ibrutinib in patients with chronic lymphocytic leukemia (CLL): A minimal residual disease(MRD)-driven, time-limited approach

Meeting Abstract

Roeker, L. E.; Leslie, L. A.; Soumerai, J. D.; Falco, V.; Panton, G.; Zelenetz, A. D.; Falchi, L.; Park, J. H.; Pena-Velasquez, C.; Lebowitz, S.; more...
Blood (2021)

Fulltext@MSK | Save

Quantifying intrathecal drug delivery utilizing programmable ventriculoperitoneal shunts

Meeting Abstract

McThenia, S.; Pandit-Taskar, N.; Grkovski, M.; Donzelli, M.; Diagana, S.; Greenfield, J.; Souweidane, M.; Kramer, K.
Neuro-Oncology Advances (2021)

Fulltext@MSK | Save

Positron emission tomography-computed tomography imaging, genomic profile, and survival in patients with head and neck cancer receiving immunotherapy

Research Letter

Fitzgerald, C. W. R.; Valero, C.; Swartzwelder, C. E.; Morris, L. G. T.
JAMA Otolaryngology - Head and Neck Surgery (2021)

Fulltext@MSK | Save

Assessing quality and safety of an advanced practice provider-led active surveillance clinic for men with prostate cancer

Journal Article

Clements, M. B.; Lin, X.; Gmelich, C.; Vertosick, E. A.; Vickers, A. J.; Manasia, M. K.; Wolchasty, N. C.; Scardino, P. T.; Eastham, J. A.; Laudone, V. P.; more...
Urology Practice (2021)

Fulltext@MSK | Save

Phase II trial of pembrolizumab plus gemcitabine, vinorelbine, and liposomal doxorubicin as second-line therapy for relapsed or refractory classical Hodgkin lymphoma

Journal Article

Moskowitz, A. J.; Shah, G.; Schöder, H.; Ganesan, N.; Drill, E.; Hancock, H.; Davey, T.; Perez, L.; Ryu, S.; Sohail, S.; more...
Journal of Clinical Oncology (2021)

Fulltext@MSK | Save

Zanubrutinib, obinutuzumab, and venetoclax with minimal residual disease-driven discontinuation in previously untreated patients with chronic lymphocytic leukaemia or small lymphocytic lymphoma: A multicentre, single-arm, phase 2 trial

Journal Article

Soumerai, J. D.; Mato, A. R.; Dogan, A.; Seshan, V. E.; Joffe, E.; Flaherty, K.; Carter, J.; Hochberg, E.; Barnes, J. A.; Hamilton, A. M.; more...
The Lancet Haematology (2021)

Fulltext@MSK | Save

COVID-19 vaccine efficacy in patients with chronic lymphocytic leukemia

Research Letter

Roeker, L. E.; Knorr, D. A.; Thompson, M. C.; Nivar, M.; Lebowitz, S.; Peters, N.; Deonarine, I. Jr; Momotaj, S.; Sharan, S.; Chanlatte, V.; more...
Leukemia (2021)

Fulltext@MSK | Save

A coordinated clinical center for young onset colorectal cancer

Editorial

Mendelsohn, R.; Palmaira, R. L.; Lumish, M.; Bacani, J.; Krishnan, A.; Weiss, J.; Semler, R.; Casson, A.; Arkema, A.; Carter, J.; more...
The Oncologist (2021)

Fulltext@MSK | Save